Marked peripheral edema associated with montelukast and prednisone.
Geller
M
M
D000085:Acetates / Q000009:adverse effects*; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000009:adverse effects*; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy; D003521:Cyclopropanes; D004347:Drug Interactions; D004487:Edema / Q000139:chemically induced*; D006801:Humans; D008297:Male; D011241:Prednisone / Q000009:adverse effects*; D011804:Quinolines / Q000009:adverse effects*; D013440:Sulfides
D000085:Acetates; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D003521:Cyclopropanes; D011804:Quinolines; D013440:Sulfides; C093875:montelukast; D011241:Prednisone